Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End-use- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global neglected tropical diseases (NTD) diagnosis market size was exhibited at USD 7.29 billion in 2022 and is projected to hit around USD 11.33 billion by 2032, growing at a CAGR of 4.5% during the forecast period 2023 to 2032.

neglected tropical diseases (NTD) diagnosis market

Key Pointers:

  • Asia Pacific held a 35.36% share of the neglected tropical diseases diagnosis market in 2022. 
  • Latin America is expected to show the fastest CAGR of 5.4% during the projected period 
  • Based on disease, soil-transmitted helminthiases dominated the market in 2022
  • The dracunculiasis segment is estimated to exhibit the fastest CAGR of 5.6% during the forecast period.
  • The molecular/modern diagnostic segment dominated the market in 2022 with a revenue share of around 50.07%,
  • point-of-care products is expected to boost the market expansion at a CAGR of 5.1% by 2032.
  • Centralized service was the largest segment in terms of market share in 2022,
  • The clinical laboratory segment held the largest market share in terms of revenue in 2022,
  • The hospitals/clinics segment held the second-largest market share in 2022

Neglected Tropical Diseases Diagnosis Market Report Scope

Report Coverage Details
Market Size in 2023 USD 7.62 Billion
Market Size by 2032 USD 11.33 Billion
Growth Rate from 2023 to 2032 CAGR of 4.5%
Base year 2022
Forecast period 2023 to 2032
Segments covered Disease, Diagnostic method, Service type, End-use
Regional scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key companies profiled F. Hoffmann-La Roche Ltd; Abbott; Thermo Fisher Scientific Inc.; ZeptoMetrix; InBios International, Inc.; Genome Diagnostics Pvt. Ltd.; Omega Diagnostics Group PLC; Coris BioConcept; DiaSys Diagnostic Systems GmbH; Oscar Medicare Pvt Ltd.

 

Growing awareness of NTDs and an increasing number of initiatives undertaken by the government are anticipated to fuel the market growth. For instance, the inclusion of NTDs in the Sustainable Development Goals (SDG), a United Nations Development Program, as a global target is anticipated to fuel market growth. Furthermore, various initiatives being undertaken by WHO, such as road map 2030 for the elimination of NTDs, are expected to drive market growth during the forecast period.

In the wake of the COVID-19 pandemic, the neglected tropical disease (NTD) diagnosis witnessed a significant decline. WHO launched the Global Program to Eliminate Lymphatic Filariasis (GPELF) in 2000, which aims to stop the spread of the infection and relieve the pain of those who have already been afflicted. However, according to the pulse survey conducted by WHO, as of early 2021, the neglected tropical disease program has faced disruptions in 45% of countries. Moreover, the high risk of transmission of SARS-CoV-2 infection has affected the public health approaches for NTDs. In countries with low health budgets, funds being shifted to tackle other diseases, and a shortage of funding from international partners and the foreign government has significantly impacted the growth of the market.

The NTD program has expanded its support to 31 countries in Asia, Latin America, and Africa. Besides, it has provided more than 2.9 billion treatments and leveraged more than USD 23.3 billion in donated medicines. Government organizations such as CDC and WHO collaborate with counties to improve existing public health services for NTDs. Moreover, in January 2022, the WHO introduced its roadmap for NTDs for the period 2023 to 2032. It is aimed to increase the prevention and control of neglected tropical diseases worldwide. Such initiatives undertaken by the government bodies are anticipated to drive the market growth during the forecast period.

Globally, several organizations initiated multiple programs, which contribute to rising in the awareness of NTDs, including the Global NTD Program by the Centers for Disease Control and Prevention, Global NTD Programs by the World Health Organization, NTD Program by the United States Agency for International Development, the United States Global Health Initiative. The primary focus of all these programs is on controlling or eliminating NTDs. Similarly, the London Declaration was initiated to sustain, expand, and extend different programs to support & control guinea worm disease, leprosy, lymphatic filariasis, sleeping sickness, trachoma, schistosomiasis, and Chagas disease by 2020.

The increasing burden of NTDs is considered to be a major factor fueling the growth of the overall market during the forecast period. According to WHO estimates, more than 1.7 billion individuals, about one-fifth of the world’s population, mostly in lower-income and developing countries-required interventions for at least one NTD every year. Around 40% of the African region was affected by NTDs. These diseases are more prevalent among the poor population living in tropical environments and difficult-to-access areas. Countries such as Brazil, Yemen, India, Bangladesh, China, and some countries in Central & East Africa contribute the majority of NTD cases globally.

Some of the prominent players in the Neglected Tropical Diseases Diagnosis Market include:

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix
  • InBios International, Inc.
  • Genome Diagnostics Pvt. Ltd.
  • Omega Diagnostics Group PLC
  • Coris BioConcept
  • DiaSys Diagnostic Systems GmbH
  • Oscar Medicare Pvt Ltd.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Neglected Tropical Diseases Diagnosis market.

By Disease 

  • Dengue
  • Chikungunya
  • Rabies
  • Leprosy
  • Buruli Ulcer
  • Yaws
  • Lymphatic Filariasis
  • Taeniasis/Cysticercosis
  • Foodborne Trematodiases
  • Echinococcosis
  • Chagas Disease (American Trypanosomiasis)
  • Dracunculiasis
  • African Trypanosomiasis
  • Soil-transmitted Helminth Infections
  • Onchocerciasis
  • Schistosomiasis
  • Scabies and Other Ectoparasites
  • Snakebite Envenoming
  • Leishmaniasis

By Diagnostic Method 

  • Conventional Method
  • Molecular/Modern Method

By Service Type 

  • Centralized Service
  • POC Service

By End-Use 

  • Clinical Labs
  • Hospitals /Clinics
  • Home Healthcare

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global neglected tropical diseases (NTD) diagnosis market size was exhibited at USD 7.29 billion in 2022 and is projected to hit around USD 11.33 billion by 2032

The global neglected tropical diseases diagnosis market is expected to grow at a compound annual growth rate of 4.5% from 2023 to 2032

Some key players operating in the neglected tropical diseases diagnosis market include Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and InBios International, Inc. among others.

The increasing burden of neglected tropical diseases, growing awareness of NTDs, and an increasing number of initiatives undertaken by the governments are the major factors driving the neglected tropical diseases diagnosis market growth over the forecast period.

Chapter 1 Methodology and Scope
                   1.1 Market segmentation & scope
                   1.2 Information procurement
                       1.2.1 Purchased database
                       1.2.2 Nova one advisor’s internal database
                       1.2.3 Secondary sources & third-party perspectives
                   1.2.4 Primary research
                   1.3 Information analysis
                       1.3.1 Data analysis models
                   1.4 Market formulation & data visualization
                   1.5 Data validation & publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Neglected Tropical Diseases Diagnosis Market Variables, Trends & Scope
                   3.1 Market Lineage outlook
                       3.1.1 Related/ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 User perspective analysis
                       3.3.1 Consumer Behavior Analysis
                       3.3.2 Market Influencer Analysis
                   3.4 Market Dynamics
                       3.4.1 Market Driver Analysis
                       3.4.2 Market Restraint Analysis
                       3.4.3 Industry Challenges
                   3.5 Neglected Tropical Diseases Diagnosis: Market Analysis Tools
                       3.5.1 Industry Analysis - Porter’s
                           3.5.1.1 Supplier Power
                           3.5.1.2 Buyer Power
                           3.5.1.3 Substitution Threat
                           3.5.1.4 Threat from new entrant
                           3.5.1.5 Competitive rivalry
                       3.5.2 PESTEL Analysis
                           3.5.2.1 Political Landscape
                           3.5.2.2 Environmental Landscape
                           3.5.2.3 Social Landscape
                           3.5.2.4 Technology Landscape
                           3.5.2.5 Legal Landscape
Chapter 4 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Disease, 2020 - 2032
                   4.1 Definitions & Scope
                   4.2 Disease market share analysis, 2023 - 2032
                   4.3 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2020 to 2032
                   4.4 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the following
                       4.4.1 Dengue
                       4.4.2 Chikungunya
                       4.4.3 Rabies
                       4.4.4 Leprosy
                       4.4.5 Buruli ulcer
                       4.4.6 Yaws
                       4.4.7 Lymphatic Filariasis
                       4.4.8 Taeniasis/Cysticercosis
                       4.4.9 Foodborne trematode infections
                       4.4.10 Echinococcosis
                       4.4.11 Chagas disease
                       4.4.12 Dracunculiasis
                       4.4.13 Human African trypanosomiasis (sleeping sickness)
                       4.4.14 Soil-transmitted helminthiases
                       4.4.15 Onchocerciasis
                       4.4.16 Schistosomiasis
                       4.4.17 Scabies and other ectoparasites
                       4.4.18 Snakebite Envenoming
                       4.4.19 Leishmaniases
Chapter 5 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Diagnostic Method, 2027 - 2032
                   5.1 Definitions & Scope
                   5.2 Diagnostic method market share analysis, 2023 & 2032
                   5.3 Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic method, 2020 to 2032
                   5.4 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the following
                       5.4.1 Conventional Method
                       5.4.2 Molecular/Modern Method
Chapter 6 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Service Type, 2020 - 2032
                   6.1 Definitions & Scope
                   6.2 Service type market share analysis, 2023 & 2032
                   6.3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2020 to 2032
                   6.4 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the following
                       6.4.1 Centralized Service
                       6.4.2 POC Service
Chapter 7 Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By End Use, 2020 - 2032
                   7.1 Definitions & Scope
                   7.2 End-use market share analysis, 2023 & 2032
                   7.3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2020 to 2032
                   7.4 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the following
                       7.4.1 Clinical Labs
                       7.4.2 Hospitals /Clinics
                       7.4.3 Home Healthcare
Chapter 8 Neglected Tropical Diseases Diagnosis Market: Regional Market Analysis, By Region, 2020 - 2032
                   8.1 Definitions & Scope
                   8.2 Regional market share analysis, 2023 & 2032
                   8.3 Regional Market Dashboard
                   8.4 Regional Market: Key Players
                   8.5 Market Size, & Forecasts, and Trend Analysis, 2023 to 2032:
                   8.6 North America
                       8.6.1 North America market estimates and forecast, 2020 - 2032
                       8.6.2 U.S.
                           8.6.2.1 U.S. market estimates and forecast, 2020 - 2032
                       8.6.3 Canada
                           8.6.3.1 Canada market estimates and forecast, 2020 - 2032
                   8.7 Europe
                       8.7.1 Europe market estimates and forecast, 2020 - 2032
                       8.7.2 Germany
                           8.7.2.1 Germany market estimates and forecast, 2020 - 2032
                       8.7.3 UK
                           8.7.3.1 UK market estimates and forecast, 2020 - 2032
                   8.8 Asia Pacific
                       8.8.1 Asia Pacific market estimates and forecast, 2020 - 2032
                       8.8.2 China
                           8.8.2.1 China market estimates and forecast, 2020 - 2032
                       8.8.3 Indonesia
                           8.8.3.1 Indonesia market estimates and forecast, 2020 - 2032
                       8.8.4 India
                           8.8.4.1 India market estimates and forecast, 2020 - 2032
                       8.8.5 Malaysia
                           8.8.5.1 Malaysia market estimates and forecast, 2020 - 2032
                   8.9 Latin America
                       8.9.1 Latin America market estimates and forecast, 2020 - 2032
                       8.9.2 Brazil
                           8.9.2.1 Brazil market estimates and forecast, 2020 - 2032
                       8.9.3 Colombia
                           8.9.3.1 Colombia market estimates and forecast, 2020 - 2032
                       8.9.4 Venezuela
                           8.9.4.1 Venezuela market estimates and forecast, 2020 - 2032
                   8.10 Middle East and Africa
                       8.10.1 Middle East and Africa market estimates and forecast, 2020 - 2032
                       8.10.2 Nigeria
                           8.10.2.1 Nigeria market estimates and forecast, 2020 - 2032
Chapter 9 Neglected Tropical Diseases Diagnosis Market - Competitive Analysis
                   9.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                   9.2 Vendor Landscape
                       9.2.1 List of key distributors and channel partners
                   9.3 Key companies profiled
                       9.3.1 F. Hoffmann-La Roche Ltd
                           9.3.1.1 Company Overview
                           9.3.1.2 Financial Performance
                           9.3.1.3 Product Benchmarking
                           9.3.1.4 Strategic Initiatives
                       9.3.2 Abbott
                           9.3.2.1 Company Overview
                           9.3.2.2 Financial Performance
                           9.3.2.3 Product Benchmarking
                           9.3.2.4 Strategic Initiatives
                       9.3.3 Thermo Fisher Scientific Inc.
                           9.3.3.1 Company Overview
                           9.3.3.2 Financial Performance
                           9.3.3.3 Product Benchmarking
                           9.3.3.4 Strategic Initiatives
                       9.3.4 ZeptoMetrix
                           9.3.4.1 Company Overview
                           9.3.4.2 Financial Performance
                           9.3.4.3 Product Benchmarking
                           9.3.4.4 Strategic Initiatives
                       9.3.5 InBios International, Inc.
                           9.3.5.1 Company Overview
                           9.3.5.2 Financial Performance
                           9.3.5.3 Product Benchmarking
                           9.3.5.4 Strategic Initiatives
                       9.3.6 Genome Diagnostics Pvt. Ltd.
                           9.3.6.1 Company Overview
                           9.3.6.2 Financial Performance
                           9.3.6.3 Product Benchmarking
                           9.3.6.4 Strategic Initiatives
                       9.3.7 Omega Diagnostics Group PLC
                           9.3.7.1 Company Overview
                           9.3.7.2 Financial Performance
                           9.3.7.3 Product Benchmarking
                           9.3.7.4 Strategic Initiatives
                       9.3.8 Coris BioConcept
                           9.3.8.1 Company Overview
                           9.3.8.2 Financial Performance
                           9.3.8.3 Product Benchmarking
                           9.3.8.4 Strategic Initiatives
                       9.3.9 DiaSys Diagnostic Systems GmbH
                           9.3.9.1 Company Overview
                           9.3.9.2 Financial Performance
                           9.3.9.3 Product Benchmarking
                           9.3.9.4 Strategic Initiatives
                       9.3.10 Oscar Medicare Pvt Ltd.
                           9.3.10.1 Company Overview
                           9.3.10.2 Financial Performance
                           9.3.10.3 Product Benchmarking
                           9.3.10.4 Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert